Rchr
J-GLOBAL ID:201801020192645440   Update date: Oct. 01, 2021

Ikumi Katano

Ikumi Katano
Papers (38):
  • Ryoji Ito, Ikumi Katano, Iyo Otsuka, Takeshi Takahashi, Hiroshi Suemizu, Mamoru Ito, Peter J Simons. Bovine β-lactoglobulin-induced passive systemic anaphylaxis model using humanized NOG hIL-3/hGM-CSF transgenic mice. International immunology. 2021. 33. 3. 183-189
  • Takuya Yamaguchi, Ikumi Katano, Iyo Otsuka, Ryoji Ito, Misa Mochizuki, Motohito Goto, Takeshi Takahashi. Generation of Novel Human Red Blood Cell-Bearing Humanized Mouse Models Based on C3-Deficient NOG Mice. Frontiers in immunology. 2021. 12. 671648-671648
  • Yuyo Ka, Ikumi Katano, Eiko Nishinaka, Jochen Welcker, Misa Mochizuki, Kenji Kawai, Motohito Goto, Kayo Tomiyama, Tomoyuki Ogura, Taichi Yamamoto, et al. Improved engraftment of human peripheral blood mononuclear cells in NOG MHC double knockout mice generated using CRISPR/Cas9. Immunology letters. 2021. 229. 55-61
  • Ryo Tsumura, Yoshikatsu Koga, Akinobu Hamada, Takeshi Kuwata, Hiroki Sasaki, Toshihiko Doi, Katsuji Aikawa, Akihiro Ohashi, Ikumi Katano, Yoshinori Ikarashi, et al. Report of the use of patient-derived xenograft models in the development of anticancer drugs in Japan. Cancer science. 2020. 111. 9. 3386-3394
  • Ikumi Katano, Ryoji Ito, Kenji Kawai, Takeshi Takahashi. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Frontiers in immunology. 2020. 11. 532684-532684
more...
MISC (3):
  • A. Miyamoto, Katano, I, Y. Kikuchi, B. Tsuda, Y. Tokuda, M. Ito, S. Habu, Y. Kametani. The specific antibody production against HER2 peptide CH401MAP in NOG-IL4-Tg mice. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 1218-1218
  • Caroline Mignard, Jean-Francois Mirjolet, Olivier Duchamp, Yasuyuki Ohnishi, Ikumi Katano, Mamoru Ito. Pharmacodynamic evaluation of ADCC mediated effects in humanized IL2 or IL15 NOG mice models. CANCER RESEARCH. 2014. 74. 19
  • Caroline Mignard, Olivier Duchamp, Jean-Francois Mirjolet, Yasuyuki Ohnishi, Ikumi Katano, Mamoru Ito. In vivo ADCC-mediated antitumor activity study with new preclinical humanized models. MOLECULAR CANCER THERAPEUTICS. 2013. 12. 11
Professional career (1):
  • 博士(医学) (慶應義塾大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page